NFKB1 and skin disorder: The release of ROS in skin is believed to activate and modulate signaling pathways that may be involved in the pathogenesis of skin disorders or dermatological diseases [57], such as the NF-kB pathway, activator protein-1 (AP-1) pathway, and mitogen-activated protein kinases (MAPK) pathway [58,59].